advertisement

Topcon

11.20 Other (8)

Showing records 1 to 8

Display all abstracts in classification 11.20 Other

Search within classification 11.20 Other
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Tanihara H
Acta Ophthalmologica 2015; 93: e254-e260
60713 Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extraction
Kraus CL
Journal of AAPOS 2015; 19: 116-118.e1
59973 Ripasudil: first global approval
Garnock-Jones KP
Drugs 2014; 74: 2211-2215
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Inoue T
Acta Ophthalmologica 2015; 93: e254-e260
60713 Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extraction
Trivedi RH
Journal of AAPOS 2015; 19: 116-118.e1
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Yamamoto T
Acta Ophthalmologica 2015; 93: e254-e260
60713 Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extraction
Wilson ME
Journal of AAPOS 2015; 19: 116-118.e1
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study
Kuwayama Y; Abe H; Suganami H; Araie M;
Acta Ophthalmologica 2015; 93: e254-e260

Issue 16-4

Change Issue


advertisement

Oculus